Rovi

Laboratorios Farmacéuticos ROVI (ROVI): All good things come in threes

Retrieved on: 
Friday, December 11, 2020
Heparins, Branches of biology, Biology, Life sciences, TiVo Corporation, Enoxaparin sodium, Vaccine, Low-molecular-weight heparin, Messenger RNA, HIBOR, Rovi, X

Laboratorios Farmacuticos ROVI's (ROVI's) recent capital markets day (CMD) highlighted the strong positioning of its three key franchises.

Key Points: 
  • Laboratorios Farmacuticos ROVI's (ROVI's) recent capital markets day (CMD) highlighted the strong positioning of its three key franchises.
  • Combined unit sales of Becat and Hibor have now overtaken incumbent Clexane sales, establishing ROVI as a leader in low molecular weight heparins (LMWHs).
  • ROVI has signed a deal to provide finished mRNA-1273 vaccine for supply ex US; this is a strong validation of its prefilled syringe fill and finish capabilities.
  • About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac.

Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

Retrieved on: 
Thursday, July 9, 2020
Health, FDA, Infectious diseases, Clinical trials, Pharmaceutical, Biotechnology, TiVo, Moderna, TiVo Corporation, Rovi, Pharmaceutical industry, Health, Companies

ROVI will also hire additional staffing required to support manufacturing operations and production.

Key Points: 
  • ROVI will also hire additional staffing required to support manufacturing operations and production.
  • We are very happy about the collaboration with Moderna, whose vaccine against COVID-19 is one of the frontrunners in the race to solve this health crisis.
  • ROVI is a pan-European pharmaceutical company specializing and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties.
  • However, while ROVI may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.